251PInfluence of first treatment delay on survival among breast cancer subtypes

ConclusionsWaiting 60 days to initiate treatment was associated with a significantly worse overall survivall among triple negative and HER2 BC. We consider it of importance to offer early treatment to aggressive BC subtypes.Legal entity responsible for the studyREDISSEC-CAMISS Group-(Research Network in Health Services in Chronic Diseases).FundingHas not received any funding.DisclosureAll authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research